Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-analysis
Lee et al.
The finding, in our words
Pooling 19 studies, FIT for colorectal cancer showed ~0.79 sensitivity and ~0.94 specificity: a moderately sensitive, highly specific single-sample stool screen, dependent on the positivity cut-off.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
This review establishes that microsampling across blood, saliva, urine and stool matrices offers validated workflows and regulatory recognition for human biomonitoring comparable to conventional methods. It finds that these decentralised approaches enhance participant acceptability and enable screening in remote or low-resource settings.
This study found that stool samples self-collected on cards showed high correlation and agreement with ethanol-fixed samples for metagenomic sequencing, with negligible differences in microbial diversity. The results support the use of stool cards as a cost-effective alternative for decentralised sampling in epidemiologic studies, despite minor variations in individual species abundance.
A systematic review and meta-analysis of interventions to raise colorectal cancer screening participation, including mailed outreach of home collection kits.
This study compared OMNIgene Gut tubes and FTA cards for stool collection in a deployed setting, finding that OMNIgene yielded higher nucleic acid concentrations while both methods detected the majority of microbial genera. The authors conclude that distinct microbial abundance profiles between the two methods necessitate standardised protocols for field research.
Researchers validated a UHPLC-MS/MS assay for citrinin in capillary blood collected with Neoteryx Mitra VAMS devices, plus feces and urine, achieving quantification limits of 0.05 ng/mL. The study derived human toxicokinetic parameters from 48-hour sample collection after a single oral dose, demonstrating that microsampling enables robust population-level exposure assessment for mycotoxins.